Search Results

There are 10121 results for: content related to: Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study

  1. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Article first published online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  2. You have free access to this content
    A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 381–388, GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI and CAMPIERI

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00482.x

  3. You have free access to this content
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1389–1399, A. H. STEINHART, A. FORBES, E. C. MILLS, B. S. RODGERS-GRAY and S. P. L. TRAVIS

    Article first published online : 30 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03324.x

  4. You have free access to this content
    Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 12, December 1998, Pages: 1207–1216, Green, Gibson, Kerr, Swarbrick, Lobo, Holdsworth, Crowe, Schofield, Taylor and THE ABACUS INVESTIGATOR GROUP

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1365-2036.1998.00427.x

  5. You have free access to this content
    Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 9, September 2000, Pages: 1191–1198, Pokrotnieks, Marlicz, Paradowski, Margus, Zaborowski and Greinwald

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00784.x

  6. You have free access to this content
    Systematic review: the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 841–855, R. BERGMAN and M. PARKES

    Article first published online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02846.x

  7. You have free access to this content
    Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 1, January 2003, Pages: 93–97, G. Aumais, M. Lefebvre, C. Tremblay, A. Bitton, F. Martin, A. Giard, M. Madi and J. Spénard

    Article first published online : 19 DEC 2002, DOI: 10.1046/j.1365-2036.2003.01409.x

  8. You have free access to this content
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1287–1296, A. BUCKLAND and K. BODGER

    Article first published online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03856.x

  9. You have free access to this content
    MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 2, July 2007, Pages: 205–215, W. J. SANDBORN, M. A. KAMM, G. R. LICHTENSTEIN, A. LYNE, T. BUTLER and R. E. JOSEPH

    Article first published online : 4 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03361.x

  10. You have free access to this content
    Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1443–1449, E. C. CHU, J. CHAI, A. AHLUWALIA and A. S. TARNAWSKI

    Article first published online : 9 APR 2007, DOI: 10.1111/j.1365-2036.2007.03336.x

  11. You have free access to this content
    MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 11, June 2008, Pages: 1094–1102, G. R. LICHTENSTEIN, M. A. KAMM, W. J. SANDBORN, A. LYNE and R. E. JOSEPH

    Article first published online : 22 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03688.x

  12. You have free access to this content
    Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 3, August 2010, Pages: 368–376, F. Hartmann, J. Stein and the BudMesa-Study Group

    Article first published online : 11 MAY 2010, DOI: 10.1111/j.1365-2036.2010.04354.x

  13. You have free access to this content
    Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 8, August 1998, Pages: 707–715, Kruis, Brandes, Schreiber, Theuer, Krakamp, Schütz, Otto, Lorenz-Mayer, Ewe and Judmaier

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1365-2036.1998.00360.x

  14. You have free access to this content
    Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 3, August 2011, Pages: 374–383, C. N. Andrews, T. A. Griffiths, J. Kaufman, N. Vergnolle, M. G. Surette and K. P. Rioux

    Article first published online : 14 JUN 2011, DOI: 10.1111/j.1365-2036.2011.04732.x

  15. You have free access to this content
    Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 3, August 2009, Pages: 245–252, R. CORINALDESI, V. STANGHELLINI, C. CREMON, L. GARGANO, R. F. COGLIANDRO, R. DE GIORGIO, G. BARTESAGHI, B. CANOVI and G. BARBARA

    Article first published online : 12 MAY 2009, DOI: 10.1111/j.1365-2036.2009.04041.x

  16. You have free access to this content
    Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 1, January 2002, Pages: 87–99, G. N. J. Tytgat, L. Van Nueten, I. Van De Velde, A. Joslyn and S. B. Hanauer

    Article first published online : 11 JAN 2002, DOI: 10.1046/j.1365-2036.2002.01121.x

  17. You have free access to this content
    Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 2, February 2000, Pages: 163–169, Wilding, Kenyon and Hooper

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00696.x

  18. You have free access to this content
    Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 11, November 1999, Pages: 1413–1417, Frieri, Pimpo, Palumbo, Onori, Viscido, Latella, Galletti, Pantaleoni and Caprilli

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00642.x

  19. You have free access to this content
    Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 2, February 2002, Pages: 207–215, N. Mahmud, D. O'Toole, N. O'Hare, P. J. Freyne, D. G. Weir and D. Kelleher

    Article first published online : 18 JAN 2002, DOI: 10.1046/j.1365-2036.2002.01155.x

  20. You have free access to this content
    Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 11, November 1998, Pages: 1101–1108, Marteau, Tennenbaum, Elefant, Lémann and Cosnes

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1365-2036.1998.00417.x